Dr. Timour Baslan

Biography

Timour Baslan, Ph.D., is an Assistant Professor in the Department of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania. His research focuses on enhancing our understanding of cancer genetics and biology, with the goal of advancing early-stage intervention and diagnostic tools for therapeutic targeting of cancer cells. Dr. Baslan employs a multidisciplinary approach that integrates sequencing and computational method development, particularly in areas like long short read sequencing, statistics, and unsupervised learning. His experimental methodologies include various cancer models and techniques such as shRNA, CRISPR, and chemical screens in vitro. His research group places particular emphasis on the role of Copy Number Alterations (CNAs) in cancer, aiming to elucidate their significance in disease initiation, progression, and therapeutic relapse. His recent work highlights the central role of CNAs in a variety of cancers, including pancreatic, breast cancers, acute leukemias, and sarcomas, underlining the importance of collaboration and cross-disciplinary investigation in cancer research.

Research Interests